Breast cancer screening a literature review
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20233497Keywords:
Breast cancer, Screening, Mammogram, BarriersAbstract
This article is looking at literature on breast cancer screening. Being the most common cancer worldwide and a leading cause of death, screening asymptotic women leads to early detection hence early treatment and with advances in treatments, breast cancer has better survival outcomes.
Metrics
References
Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast. 2022;66:15-23.
Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet. 2000;355(9217):1822.
Hashim MJ, Al-Shamsi FA, Al-Marzooqi NA, Al-Qasemi SS, Mokdad AH, Khan G. Burden of breast cancer in the Arab world: findings from Global Burden of Disease. J Epidemiol Global Heal. 2018;8(1-2):54.
Ouanhnon L, Bugat MER, Lamy S, Druel V, Delpierre C, Grosclaude P. Social and territorial inequalities in breast and cervical cancers screening uptake: a cross-sectional study in France. BMJ Open. 2022;12(2):e055363.
Siu AL, US Preventive Services Task Force. Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Internal Med. 2016;164(4):279-96.
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty-five-year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study Randomised Screening trial. BMJ. 2014;348.
Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Brit J Cancer. 2013;108(11):2205-40.
Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Internal Med. 2009;151(10):727-37.
Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359(9310):909-19.
Autier P, Koechlin A, Smans M, Vatten L, Boniol M. Mammography screening and breast cancer mortality in Sweden. J National Cancer Inst. 2012;104(14):1080-93.
Gøtzsche PC, Jørgensen KJ, Cochrane Breast Cancer Group. Screening for breast cancer with mammography. Cochrane Database Systematic Rev. 1996;2013(6).
Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Eng J Med. 2005;353(17):1784-92.
Weedon-Fekjær H, Romundstad PR, Vatten LJ. Modern mammography screening and breast cancer mortality: population study. BMJ 2014;348.
Otto SJ, Fracheboud J, Verbeek AL, Boer R, Reijerink-Verheij JC, Otten JD et al. Mammography screening and risk of breast cancer death: a population-based case–control study. Cancer Epidemiol Biomarkers Prevention. 2012;21(1):66-73.
Elmore JG, Reisch LM, Barton MB, Barlow WE, Rolnick S, Harris EL, et al. Efficacy of breast cancer screening in the community according to risk level. J National Cancer Inst. 2005;97(14):1035-43.
Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-cancer screening-viewpoint of the IARC Working Group. N Eng J Med. 2015;372(24):2353-8.
Brown ML, Houn F, Sickles EA, Kessler LG. Screening mammography in community practice: positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. Am J Roentgenol. 1995;165(6):1373-7.
Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Internal Med. 2011;155(8):481-92.
Christiansen CL, Wang F, Barton MB, Kreuter W, Elmore JG, Gelfand AE, et al. Predicting the cumulative risk of false-positive mammograms. J National Cancer Inst. 2000;92(20):1657-66.
Barton MB, Morley DS, Moore S, Allen JD, Kleinman KP, Emmons KM, et al. Decreasing women's anxieties after abnormal mammograms: a controlled trial. J National Cancer Inst. 2004;96(7):529-38.
Coldman A, Phillips N. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program. CMAJ. 2013;185(10):E492-8.
Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Bri J Cancer. 2013;108(11):2205-40.
Welch HG, Prorok PC, O’Malley AJ, Kramer BS. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Eng J Med. 2016;375(15):1438-47.
Wadhwa A, Sullivan JR, Gonyo MB. Missed breast cancer: what can we learn? Curr Prob Diagnostic Radiol. 2016;45(6):402-19.
Lamb LR, Mohallem Fonseca M, Verma R, Seely JM. Missed breast cancer: effects of subconscious bias and lesion characteristics. Radiographics, 2020;40(4):941-60.
Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, et al. National performance benchmarks for modern screening digital mammography: update from the Breast Cancer Surveillance Consortium. Radiology. 2017;283(1):49-58.
Mamdouh HM, El-Mansy H, Kharboush IF, Ismail HM, Tawfik MM, El-Baky MA, et al. Barriers to breast cancer screening among a sample of Egyptian females. J Family Community Med. 2014;21(2):119.
Tsapatsaris A, Babagbemi K, Reichman MB. Barriers to breast cancer screening are worsened amidst COVID-19 pandemic: A review. Clin Imaging, 2022;82:224-7.
Alter RC, Yaffe MJ. Breast cancer screening and anxiety. J Breast Imaging. 2021;3(3):273-5.
Bonfill Cosp X, Marzo Castillejo M, Pladevall Vila M, Marti J, Emparanza JI, Cochrane Breast Cancer Group. Strategies for increasing the participation of women in community breast cancer screening. Cochrane Database Systematic Rev. 1996;2016(9).
Brown SL, Gibney TM, Tarling R. Busy lifestyles and mammography screening: time pressure and women’s reattendance likelihood. Psychol Health. 2013;28(8):928-38.
Battaglia TA, Roloff K, Posner MA, Freund KM. Improving follow‐up to abnormal breast cancer screening in an urban population: a patient navigation intervention. Cancer Interdisciplinary Int J Am Cancer Society. 2007;109(S2):359-67.
Naz MSG, Simbar M, Fakari FR, Ghasemi V. Effects of model-based interventions on breast cancer screening behavior of women: a systematic review. Asian Pacific J Cancer Prevent 2018;19(8):2031.
Deppen SA, Aldrich MC, Hartge P, Berg CD, Colditz GA, Petitti DB, et al. Cancer screening: the journey from epidemiology to policy. Ann Epidemiol. 2012;22(6):439-45.
Downloads
Published
How to Cite
Issue
Section
